The animals that nourish us deserve the best health possible

About us

At Acceligen, we care about the health and well-being of the animals that provide sustenance to the world.

We're a leader in precision breeding, a proven technology that addresses long-standing challenges in animal health and caretaking. Our team is working with farmers and ranchers worldwide to help them provide safe, abundant food by raising healthier animals in a more sustainable manner.

We're part of a team of experts pursuing solutions to global food security, an urgent issue as populations rise, cropland shrinks, and the climate changes.

We envision that with our technology, global consumers will have better access to the meat and dairy products they enjoy, and farmers will be able to raise fewer animals using less natural resources.


Our expertise

Our ability to precisely deliver traits based on gene editing technology provides animal breeders new opportunities to accelerate genetic improvement. By introducing unique and valuable genetics, we can dramatically shorten the development cycles typical with conventional selective breeding.

Our work has been documented in over 300 peer-reviewed publications and written been covered many times by both scientific and consumer media outlets.


Our technology

We're innovating Precision Breeding using the latest advances in animal genetics science to develop, test and deliver the safest and most precise solutions to better food animal health and well-being.

The tools of Precision Breeding, including CRISPR/Cas9 and TALENS, are widely used by scientists around the world working in public and private institutions focused on improving human and animal health, agriculture, energy, and environmental sciences. More than 20,000 peer-reviewed publications are describing how these tools work and their efficacy.

We've received numerous competitive grants from different agencies within the USDA and others to pursue answers to problems that have long challenged current agricultural practices.


Our team

The Acceligen team includes renown animal geneticists, scientists, business experts, ranchers, farmers, partners, consumers, academics, public policymakers, collaborators, specialized staff and advisors from many backgrounds who weigh-in on the ethical deployment of our technologies.

tad headshot

Tad Sonstegard, Ph.D.

Chief Executive & Scientific Officer
Dr. Tad Sonstegard is an internationally recognized leader in livestock genetics with more than 20 years of experience in the field. Tad has made seminal contributions to the sequencing of livestock genomes, development of industry-standard genetic diagnostic platforms and elucidation of the genetic basis for traits impacting food animal health, production, and well-being. Before joining the Recombinetics team, Tad developed and led federally funded projects in applied genomics for ruminant genetic improvement at the USDA Agricultural Research Service’s Animal Genomics & Improvement Laboratory. He holds a bachelor’s degree in Agricultural Biochemistry from Iowa State University and a Ph.D. in Molecular, Cellular, Developmental Biology and Genetics from the University of Minnesota.
sabreena preferred 2 (3)

Sabreena Larson. M.S.

Director of Commercial Operations
Previously to joining Acceligen, Ms. Larson worked at the world’s largest agricultural genotyping lab, GeneSeek, where she was a Key Account Manager working with the top genetics companies for protein and dairy production. She also managed a data service group, that transforms raw data into reports producers could use to make selection decisions within their herd. She holds a bachelor's degree in biology from Nebraska Wesleyan University and a master’s degree in Biochemistry from the University of Nebraska-Lincoln. Ms. Larson has been around agriculture from a young age, growing up in a small agricultural community in Nebraska.

Acceligen is a wholly owned subsidiary of Recombinetics, Inc., a recognized leader in the development and deployment of proprietary gene editing technologies.

Founded in 2008, Recombinetics is a privately-held, Minnesota-based biotechnology company delivering viable products and generating revenues today from the large and growing biomedical and agricultural markets. The company’s achievements in animal gene-editing have received international recognition from the New York Times, BBC and other prestigious media and scientific journals worldwide.

Recombinetics' leading position in gene editing is based on its strong intellectual property foundation, which includes a global licensed technology combined with owned technologies protected by utility patents covering both products and methods of gene editing.